HMOX1 and tuberculosis: Recently, Petrillo et al. reported the personalized profiles of antioxidant signaling pathway in patients with tuberculosis, and TB treatment strategies based on changing the redox environment in vivo should be individually designed according to the characteristics of each patient and the degree of disease progression as their variability of Nrf2, GSH, HO1, and SOD expression levels [70].